PIM
CVAC

Platinum Investment Management’s CureVac CVAC Stock Holding History

Platinum Investment Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-626,684
Closed -$1.9M – 141
2024
Q1 		$1.9M Buy
626,684
+128,778
+26% +$452K 0.08% 71
2023
Q4 		$2.1M Buy
497,906
+134,626
+37% +$730K 0.09% 79
2023
Q3 		$2.48M Buy
363,280
+137,146
+61% +$1.21M 0.1% 75
2023
Q2 		$2.36M Buy
+226,134
New +$2.02M 0.08% 76
2021
Q3 		– Sell
-21,132
Closed -$1.55M – 150
2021
Q2 		$1.55M Sell
21,132
-23,668
-53% -$2.37M 0.04% 104
2021
Q1 		$4.1M Buy
44,800
+28,177
+170% +$2.73M 0.09% 63
2020
Q4 		$1.35M Sell
16,623
-52,553
-76% -$4.02M 0.03% 105
2020
Q3 		$3.22M Buy
+69,176
New +$3.86M 0.08% 65

Other funds holding CVAC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Platinum Investment Management's CVAC Position: Q2 2024 in Review

Platinum Investment Management sold out of CureVac (CVAC) in Q2 2024, closing a stake of 626,684 shares — an estimated $1.9M sold.

Platinum Investment Management first reported a position in CVAC in Q3 2020 and held it in 8 quarters. The position peaked at $4.1M in Q1 2021. 87 funds tracked by Wall St. Rank hold CVAC as of Q2 2024.

  • Platinum Investment Management reported no remaining CureVac position as of Q2 2024 after selling out during the quarter.
  • Platinum Investment Management sold 626,684 CureVac shares in Q2 2024, an estimated $1.9M.
  • Platinum Investment Management first reported a position in CureVac in Q3 2020 and held it in 8 quarters.
  • Platinum Investment Management's CureVac position peaked at $4.1M in Q1 2021.
  • 87 funds tracked by Wall St. Rank held CureVac as of Q2 2024.

Based on Platinum Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.